Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Hepatitis B Diagnostic Tests Market Outlook from 2023 to 2033

The hepatitis B diagnostic tests market size was projected to be worth US$ 872.5 million in 2022. By the end of 2023, the market is likely to reach a valuation of US$ 872.5 million. The global market for hepatitis B diagnostic tests is likely to garner a 6.5% CAGR and reach a market worth US$ 1744.26 million by 2033.

Key Market Trends and Highlights

  • Growing hepatitis B incidence: A rise in hepatitis B cases throughout the world, particularly in high-prevalence areas, increases the need for diagnostic tests and propels market expansion.
  • Awareness initiatives: Public health programs and healthcare campaigns encourage hepatitis B testing, which raises awareness and improves diagnosis rates.
  • Diagnostic technology advancements: Constant innovation in the field of diagnostics improves test sensitivity, accuracy, and speed, spurring acceptance and market expansion.
Attributes Key insights
Estimated Market Value in 2022 US$ 872.5 million
Expected Market Value in 2023 US$ 872.5 million
Expected Market Value in 2033 US$ 1744.26 million
Value-based CAGR from 2023 to 2033 6.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Historical Analysis vs. 2023 to 2033 Market Forecast Projections

During the historical period, 2018 to 2022, the hepatitis B diagnostic tests market grew at CAGR of 4.5%.

Report Attributes Details
Market value in 2018 US$ 678.21 million
Market value in 2022 US$ 872.5 million
CAGR from 2018 to 2022 4.5%

The need for hepatitis B diagnostic tests is significantly increased by public health efforts and screening programs. To inform people about the dangers of hepatitis B and the value of testing, healthcare organizations, governments, and non-governmental organizations frequently conduct awareness campaigns as well as screening programs.

The general public and healthcare professionals become more informed as a result of these initiatives, which raise the rates of screening and diagnosis. The market for hepatitis B diagnostic tests is driven by rising testing rates and better access to testing facilities.

Hepatitis B Diagnostic Tests Market Key Drivers

  • The market for diagnostic tests is significantly being driven by the increased incidence of hepatitis B globally. With millions of people infected, hepatitis B is a major cause of liver disease as well as liver cancer and a global health problem. Healthcare systems and providers are under more and more pressure to identify and treat the illness as the number of infected people rises.
  • This increases the need for hepatitis B diagnostic testing, particularly in areas where the infection is more common. The industry is expanding in part due to the routine screening techniques for at-risk individuals are being adopted.
  • The market for hepatitis B diagnostic tests is significantly impacted by ongoing improvements in diagnostic technology. Test accuracy, sensitivity, and specificity have all increased as a result of advancements in assay techniques including enzyme immunoassays as well as nucleic acid testing.
  • Faster and more convenient testing is now possible because to the development of fast diagnostic tests as well as point-of-care equipment, which is especially useful in environments with limited resources. The development of the market is fueled by technology improvements that not only improve diagnostic capabilities but also encourage laboratories along with healthcare providers to use these more precise and effective testing techniques.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the Hepatitis B Diagnostic Tests Market

  • Despite the rise in hepatitis B testing demand, having access to healthcare facilities is still a major problem, especially in underdeveloped and rural regions. Diagnostic tests may not be as accessible as they could be if there was insufficient healthcare infrastructure, including a lack of testing facilities and qualified medical staff.
  • Hepatitis B stigma and false information about the condition might deter people from being tested. Some people may put off being tested or delaying getting medical care out of fear of social prejudice or misunderstandings regarding transmission modalities. In order to make sure that people at risk for hepatitis B get tested and identified as soon as possible, overcoming stigma and increasing knowledge of the value of testing are crucial tasks. Public health initiatives and education campaigns are essential in tackling these issues.

Comparative View of Adjacent Markets

Future Market Insights has compared two other markets, namely Antigen Skin Test Market and Zika Virus Testing Market below. This shows that Hepatitis B Diagnostic Tests industry is set to dominate out of these three markets over the forecast period 2023 to 2033.

Hepatitis B Diagnostic Tests Market:

CAGR from 2023 to 2033 6.5%
Market Value in 2033 US$ 1744.26 million
Key Trends
  • The market demand and testing rates for hepatitis B are increasing as a result of growing public health awareness.
  • Disease eradication initiatives generate opportunity for test makers and healthcare professionals.
Key Opportunities
  • Expansion into underdeveloped locations with high hepatitis B incidence offers tremendous development possibilities in emerging markets.
  • The development of novel diagnostic technologies along with point-of-care diagnostics opens up new business prospects.

Antigen Skin Test Market:

CAGR from 2023 to 2033 5.2%
Market Value in 2033 US$ 3,548.63 million
Key Trends
  • Changing lifestyles along with environmental factors are contributing to a rise in the prevalence of allergy diseases globally.
  • Antigen skin tests are a highly effective diagnostic approach for diagnosing allergies, and demand for them is expected to rise.
Key Opportunities
  • To capitalize on the opportunities presented by the antigen skin test market's unrealized potential, businesses recently made significant investments in the creation of innovative tests.
  • Antigen methods for identification are evolving as technology advances, allowing for more precise allergy diagnosis.

Zika Virus Testing Market:

CAGR from 2023 to 2033 3.4%
Market Value in 2033 US$ 6.8 million
Key Trends
  • Numerous significant factors, such as the increasing emergency permission of POCT testing, are driving up demand for Zika virus testing.
  • The Zika virus therapeutics market is being driven by the swift technical advancements and improved research and development in the field of Zika virus RNA treatment.
Key Opportunities
  • Growth will be aided by rising demand for glycerol Hepatitis B Diagnostic Tests from the lubricant industry, which is associated with the expanding automotive sector.
  • The global glycerol Hepatitis B Diagnostic Tests market will expand as a result of the rising use of glycerol Hepatitis B Diagnostic Tests in textile chemicals and anti fogging agents.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Below mentioned is the table of top five countries that are anticipated to gain a significant growth rate during the forecast period. Among these countries, the maximum growth is expected from two specific countries, namely the United States and China.

Forecast CAGRs from 2023 to 2033

Country Expected market share in 2023
The United States 34.7%
China 23.2%
Japan 7.1%
France 8.0%
The United Kingdom 7.8%

Public Awareness towards Health to Boost Sales in the United States Market

In 2023, the United States market for Hepatitis B Diagnostic Tests is anticipated to take over 34.7% market share. In the United States, there is a higher demand for diagnostic tests as people become more aware of the necessity of hepatitis B testing along with the accompanying health hazards.

More people are being screened for hepatitis B through various educational activities, public health campaigns, and healthcare practitioner recommendations. This increased awareness has resulted in higher test rates and increased demand for diagnostic tests.

Hepatitis B is the most common cause of liver illness and malignancy. Individuals, particularly those with associated risks like a family history of hepatitis B or particular habits, are increasingly seeking preventative healthcare due to the significance of liver health.

Hepatitis B testing on a regular basis allows for early identification and treatment, which can help avoid liver damage and problems. The focus on preventative medicine and to live a better way is bolstering the regional demand all across the United States.

Government Initiatives to Restrict the Virus may Boost Demand in China

In 2023, China is anticipated to acquire 23.2% of the global market shares for hepatitis B diagnostic tests. As per WHO, China has the world's highest prevalence of hepatitis B cases. Currently, there are approximately 70 million HBV-infected persons in China. To alleviate this burden, immunization, counseling, and early detection will be critical. The Chinese government has also initiated a number of programs aimed at eradicating this deadly disease by 2030. To achieve this purpose, it collaborates closely with international bodies such as WHO.

A sizable portion of the population in China is at an increased risk for hepatitis B owing to the virus's high prevalence in some areas and its numerous transmission routes. Children born to hepatitis B-positive mothers are among those at risk, resulting in increasing need for child and maternal health screening along with general hepatitis B screening.

In recent years, China has undergone considerable healthcare reforms, with an emphasis on increasing healthcare availability and quality. The government's effort to promote public health includes programs to improve hepatitis B awareness and extend access to diagnostic services. These initiatives have contributed to increasing demand for hepatitis B testing as greater numbers of individuals seek screening as well as prompt detection.

Japan Medical Tourism to Accelerate Market Growth

The hepatitis B diagnostic tests market in Japan will gain 7.1% of the global market share by the end of 2023. Japan is drawing an increasing number of medical tourists looking for superior healthcare treatments. Hepatitis B testing may be required for some of these medical tourists as part of the pre-surgical or pre-treatment evaluations. This surge of overseas patients increases need for diagnostic testing.

Japan's population is aging, and elderly people are more likely to develop problems from an ongoing infection with hepatitis B. The healthcare system in the nation places a heavy focus on regular medical examinations and preventative treatment for elders. There is an increasing demand for hepatitis B diagnostic tests for tracking and managing the senior population's health.

France’s Cultural Diversity to Boost Growth in France

The hepatitis B diagnostic tests market in France is anticipated to gain 8% market share by 2023. France is well-known for its outstanding healthcare system along with universal coverage. Preventive treatments and frequent screenings are stressed as part of comprehensive healthcare. Screening for Hepatitis B is frequently advised and given to a wide spectrum of patients, leading to the continued need for diagnostic testing.

France's population is varied, including immigrants from locations with differing hepatitis B incidence rates. Individuals from these areas are frequently advised by healthcare experts to be tested for hepatitis B. The need for diagnostic testing is driven by cultural diversity along with healthcare access legislation.

Liver Awareness Programs to Bolster Demand in the United Kingdom

The United Kingdom Hepatitis B Diagnostic Tests market is expected to acquire a 7.8% market share by 2023. The United Kingdom has various launched immunization efforts to prevent both acute and demand for Chronic Hepatitis B Virus Testing. As part of these initiatives, healthcare clinicians may suggest hepatitis B testing to those who are at high risk owing to their travel history, work, or other reasons. This emphasis on immunization and focused testing leads to the increased demand for hepatitis B diagnostic tests in the United Kingdom.

The country also places a major emphasis on liver disorder awareness and research. Many organizations and universities perform considerable research on liver illnesses such as hepatitis B. Increased screening as well as diagnostic testing is frequently the result of this investigation, particularly in high-risk groups.

The National Health Service (NHS) in the United Kingdom provides comprehensive medical services to inhabitants. Frequent health check-ups as well as screening programs are essential components of the NHS's preventative care strategy. Hepatitis B testing is offered in some screening programs and thus advised for at-risk persons, which adds to the need for diagnostic tests.

Category-wise Insights

The below table highlights how the enzyme immunoassay kits are projected to lead the global market in terms of product type. These products are expected to acquire 71.90% market share in 2023.

The hepatitis B diagnostic tests being used up in hospitals sector have gained immense traction in the last few years. During the forecast period, the hospitals segment will grow with a fast 6.2% CAGR.

Category Market share in 2023/ CAGR(2023 to 2033)
Enzyme immunoassay kits 71.9%
Hospitals 6.2%

Enzyme Immunoassay Kits to Gain Prominence for Better Hepatitis B Diagnosis

Enzyme immunoassay kits account for over 70% of the global hepatitis B diagnostic tests market. It is anticipated to expand profitably at a CAGR of 6.2% in the next ten years.

The enzyme immunoassay kits are commonly employed in the detection of hepatitis B infection due to their dependability and ease of use. Since enzyme immunoassay kits are made to be extremely specific and highly sensitive, they can accurately detect even minute levels of hepatitis B surface antigen (HBsAg) or antibodies. They can therefore distinguish between instances that are acute and those that are chronic and are useful for early infection diagnosis.

Results from enzyme immunoassay kits are normally available in a matter of hours. This short turnaround time is beneficial for patients as well as healthcare providers since it enables prompt hepatitis B diagnosis and treatment, which can lower the risk of complications and transmission.

Hospitals to Boost Sales in Global Hepatitis B Diagnostic Tests Industry

Based on end-use, the hospitals segment is expected to continue gaining traction in the global hepatitis B diagnostic tests industry. The segment is anticipated to gain a CAGR of 6.2% throughout the forecast period.

The population of prospective patients who might use medical services is expanding along with the number of hospitals. Hospitals are important healthcare centers where people frequently undergo testing for various kind of diseases including hepatitis B diagnosis. This bigger patient pool raises the need for hepatitis B diagnostic tests, which expands the market.

The geographic reach of healthcare services can be increased via the construction of new hospitals, especially in underserved or distant locations. Groups that may have previously had limited access to hepatitis B diagnostic tests may now have greater access to them. As more individuals are tested for hepatitis B, the wider scope of diagnostic testing may aid in the growth of global Hepatitis - B Therapeutics.

Competitive Landscape

Manufacturers of HBV diagnostics tests make investments in research and development to provide cutting-edge, novel testing products. Enhanced test sensitivity and specificity, shorter turnaround times, intuitive user interfaces, and interoperability with automated laboratory equipment are a few examples of these improvements.

Manufacturers want to gain market share and satisfy the rising need for precise and effective testing procedures by releasing new and enhanced diagnostic assays and instruments.

Some of the prominent developments by key companies in this domain are:

Company Key Developments
Gilead Sciences, Inc.
  • In 2022, the Partnership for Health Advancement in Vietnam (HAIVN), a joint venture of Brigham and Women's Hospital, Harvard University, and Beth Israel Deaconess Medical Center, welcomed Gilead Sciences, Inc. as a partner.
  • In Vietnam as well as the Philippines, these two nations with significant hepatitis B burdens, the multi-year program is intended to assist overcome hurdles that prevent viral hepatitis B diagnosis and treatment at basic healthcare facilities.
Abbott
  • In 2022, in order to enhance the detection of the Hepatitis B virus (HBV), Abbott introduced the HBsAg next generation solution in India.
  • The early and improved detection of HBV in human blood, plasma samples, and population screening is made possible by this incredibly sensitive chemiluminescent microparticle immunoassay (CMIA).
GSK
  • In 2023, GSK is currently conducting research to combine Bepirovirsen with other medicines (pegylated interferon, vaccination, PAPD5 and PAPD7 enzyme inhibitors) in order to boost the efficacy of the medication therapy for chronic hepatitis B.
  • Bepirovirsen is a drug with highly promising outcomes for curing the disease.

Report Scope

Attribute Details
Projected market value in 2023 US$ 872.5 million
Projected market value in 2033 US$ 1744.26 million
Forecast CAGR from 2023 to 2033 6.5%
Forecast period 2023 to 2033
Historical period 2018 to 2022
Market analysis Value in US$ million
Key regions covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa
Key countries profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key market segments
  • Product Type,
  • End-user
  • Region
Key companies profiled
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • Abbott Laboratories
  • Meridian Bioscience
  • bioMérieux SA Inc.
  • Vista Diagnostics International
  • Biogate Laboratories Ltd.
  • J.Mitra & Co. Ltd.
  • Siemens Medical Solutions USA, Inc.
  • General Biologicals Corporation

Segmentation Analysis of the Hepatitis B Diagnostic Tests Market

By Product Type:

  • Enzyme Immunoassay Kits
    • Hepatitis B Surface Antigen Test
    • Anti-Hepatitis B Surface Antibody Test
    • Anti-Hepatitis B Core Antibody Test
  • Point-of-Care Testing Kits
    • Strips
    • Cassettes/Cards

By End User:

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Home Care

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa

Frequently Asked Questions

What is the anticipated market value of the hepatitis B diagnostic tests market in 2023?

The hepatitis B diagnostic tests market is expected to reach US$ 872.5 million by 2023.

What is the expected CAGR for the hepatitis B diagnostic tests market until 2033?

The global Hepatitis B Diagnostic Tests market is set to expand by a CAGR of 6.5% by 2033.

What is the anticipated valuation of the market in 2033?

The hepatitis B diagnostic tests industry is forecast to reach US$ 1744.26 million by 2033.

Which product is likely to dominate the hepatitis B diagnostic tests market?

The enzyme immunoassay test kits are expected to acquire over 70% in 2023 and same trend will continue.

Which is the leading end-user in the Hepatitis B Diagnostic Tests domain?

Through 2033, the hospitals segment will garner over 6% CAGR.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Enzyme Immunoassay Kits

            5.3.1.1. Hepatitis B Surface Antigen Test

            5.3.1.2. Anti-Hepatitis B Surface Antibody Test

            5.3.1.3. Anti-Hepatitis B Core Antibody Test

        5.3.2. Point-of-Care Testing Kits

            5.3.2.1. Strips

            5.3.2.2. Cassettes/Cards

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Clinics

        6.3.3. Diagnostic Centres

        6.3.4. Home Care

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Product Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Product Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Product Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Product Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product Type

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Product Type

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product Type

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product Type

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product Type

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product Type

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product Type

            15.5.2.2. By End User

    15.6. UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product Type

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product Type

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product Type

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product Type

            15.9.2.2. By End User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product Type

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product Type

            15.11.2.2. By End User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product Type

            15.12.2.2. By End User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product Type

            15.13.2.2. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product Type

            15.14.2.2. By End User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product Type

            15.15.2.2. By End User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product Type

            15.16.2.2. By End User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product Type

            15.17.2.2. By End User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Product Type

            15.18.2.2. By End User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Product Type

            15.19.2.2. By End User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Product Type

            15.20.2.2. By End User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Product Type

            15.21.2.2. By End User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Product Type

            15.22.2.2. By End User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Product Type

            15.23.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product Type

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Bio-Rad Laboratories, Inc.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. DiaSorin S.p.A.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Abbott Laboratories

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Meridian Bioscience

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. bioMérieux SA Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Vista Diagnostics International

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Biogate Laboratories Ltd.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. J.Mitra & Co. Ltd.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Siemens Medical Solutions USA, Inc.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. General Biologicals Corporation

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Thyroid Function Test Market

Published : October 2023

Healthcare

Antigen Skin Test Market

Published : March 2023

Healthcare

Zika Virus Testing Market

Published : December 2022

Healthcare

Blood Culture Test Market

Published : October 2022

Explore Healthcare Insights

View Reports

Hepatitis B Diagnostic Tests Market